| Literature DB >> 31036010 |
Xiongfa Liang1, Yongchang Lai1, Weizhou Wu1, Dong Chen1, Fangling Zhong1, Jian Huang1, Tao Zeng1, Xiaolu Duan1, Yapeng Huang1, Shike Zhang1, Shujue Li1, Wenqi Wu2.
Abstract
BACKGROUND: To explore long-non-coding RNA (lncRNA), microRNA (miRNA) and messenger RNA (mRNA) expression profiles and their biological functions in the urine samples in calcium oxalate (CaOx) patients.Entities:
Keywords: Calcium oxalate; Competing endogenous RNA network; Kidney stone; LncRNA; MiRNA; Urine
Mesh:
Substances:
Year: 2019 PMID: 31036010 PMCID: PMC6489260 DOI: 10.1186/s12920-019-0502-y
Source DB: PubMed Journal: BMC Med Genomics ISSN: 1755-8794 Impact factor: 3.063
Characteristics of the study subjects
| Traits | Stone-forming group ( | Normal group ( | P Value |
|---|---|---|---|
| Age (±SD), (years) | 31.00 ± 7.40 | 31.67 ± 2.81 | 0.858 |
| Height (±SD), (cm) | 166.20 ± 3.25 | 170.33 ± 6.92 | 0.969 |
| Weight (±SD), (kg) | 68.20 ± 13.06 | 68.50 ± 9.29 | 0.296 |
| Mean stone burden (±SD), (cm2) | 2.58 ± 1.04 | – | – |
| Hydronephrosis, n (%) | 5 (100%) | – | – |
Fig. 4qRT-PCR was performed to confirm the expression of nine miRNAs, 10 selected mRNAs and 10 selected lncRNAs in HK-2 cells treated by NaOx. a miRNAs accord with microarray results confirmed by qRT-PCR; (b) miRNAs unsatisfied with microarray results confirmed by qRT-PCR; (c) mRNAs accord with microarray confirmed by qRT-PCR; (d) mRNAs unsatisfied with microarray results confirmed by qRT-PCR; (e) lncRNAs accord with microarray results confirmed by qRT-PCR and (f) lncRNAs unsatisfied with microarray results confirmed by qRT-PCR. Results are presented as mean ± SEM. * represents P < 0.05 in comparison with the corresponding group. n = 3. n = 1 represent an independent cell culture
Total differentially expressed miRNAs between stone-forming and normal group
| Upregulated miRNAs | Downregulated miRNAs | Fold change | |
|---|---|---|---|
| hsa-miR-4723-3p | 4.4706 | 0.0452 | |
| hsa-miR-6804–3p | 3.5887 | 0.0291 | |
| hsa-miR-6796-3p | 3.2221 | 0.0486 | |
| hsa-miR-6799-3p | 3.0989 | 0.0263 | |
| hsa-miR-518b | 3.4838 | 0.0135 | |
| hsa-miR-3192–3p | 2.5749 | 0.0423 | |
| hsa-miR-30d-5p | 2.3468 | 0.0361 | |
| hsa-miR-767-3p | 1.6135 | 0.0308 | |
| hsa-miR-6776-3p | 1.5331 | 0.0231 |
Top 10 up- and downregulated mRNAs between stone-forming and normal group
| Upregulated mRNAs | Fold change | P value | Downregulated mRNAs | Fold change | P value |
|---|---|---|---|---|---|
| NT5E | 11.3689 | 1.51E-06 | RNU6-43P | 3.7423 | 0.0177 |
| CDH4 | 8.5574 | 6.08E-05 | BCL2L14 | 3.0199 | 0.0045 |
| NBPF15 | 6.3077 | 0.0411 | UBAC1 | 2.7921 | 0.0028 |
| IGLJ4 | 5.6031 | 4.01E-04 | GULP1 | 2.6563 | 0.0177 |
| TAF1 | 4.4195 | 2.20E-04 | CLEC14A | 2.5972 | 0.0089 |
| ANGPTL3 | 4.1717 | 0.0018 | CCNL1 | 2.5964 | 6.58E-05 |
| METTL2B | 4.1713 | 3.50E-04 | CASP4 | 2.5553 | 0.0222 |
| ASCC2 | 3.9391 | 0.0497 | SLC41A3 | 2.5178 | 0.0019 |
| RPS26 | 3.6909 | 0.0059 | CAMK2G | 2.4968 | 0.0198 |
| NUP62CL | 3.5754 | 0.0056 | PDK4 | 2.4216 | 0.0016 |
Top 10 up- and downregulated lncRNAs between stone-forming and normal group
| Upregulated mRNAs | Fold change | P value | Downregulated miRNAs | Fold change | P value |
|---|---|---|---|---|---|
| lnc-STX11–4 | 9.2496 | 0.0435 | lnc-WHSC1L1–11 | 2.9871 | 0.0091 |
| lnc-ALKBH4–8 | 7.7525 | 0.0363 | lnc-FAM72B-4 | 2.5733 | 0.0013 |
| lnc-KIF24–2 | 6.8555 | 0.0342 | RNY4 | 2.5414 | 0.0230 |
| lnc-CHCHD7–9 | 6.5116 | 0.0454 | RP11-717A5.2 | 2.4464 | 0.0013 |
| lnc-BAGE4–3 | 6.0793 | 0.0372 | lnc-EVI5L-1 | 2.2651 | 6.11E-04 |
| lnc-TIGD1L2–3 | 5.6854 | 0.0309 | SNAR-C4 | 2.2332 | 0.0062 |
| lnc-OPRD1–5 | 5.5862 | 0.0184 | lnc-GPR31–3 | 2.2059 | 0.0212 |
| lnc-KIN-1 | 5.4314 | 0.0157 | lnc-SERPINI1–2 | 2.1009 | 0.0057 |
| lnc-VPS45–7 | 5.3865 | 0.0372 | C12orf36 | 2.0226 | 0.0023 |
| lnc-C12orf53–1 | 5.2731 | 0.0322 | lnc-MB-6 | 2.0219 | 0.0095 |
Fig. 1Hierarchical clustering and volcano plots of dysregulated miRNA, mRNA and lncRNA. Hierarchical clustering shows all dysregulated miRNAs (a), mRNAs (c) and lncRNAs (e) in the urine sample of CaOx group (sample 1–5) and normal group (sample 6–11). Red represents high relative expression and blue represents low relative expression. Volcano plots were performed to assess the variation and reproducibility of miRNAs (b), mRNAs (d) and lncRNAs (f) expression between CaOx and normal urine sample. Red spots indicate upregulated genes, while blue spots represent downregulated genes
Fig. 2Venn diagram of dysregulated mRNA and miRNA expression profile detected in two studies. a One miRNA was found to be significant both in our previous studies in the CaOx rat model and in this study of urine from CaOx patient; (b) 131 mRNAs were found to be significant both in our previous studies and in our present study. CaOx, calcium oxalate
Fig. 3CeRNA network responded to the miRNA, mRNA and lncRNA variations in urine of CaOx stone patients. There were nine miRNA nodes, 141 mRNA nodes and 65 lncRNA nodes in this network. Blue triangles represent miRNAs, green squares represent lncRNAs, and red circles represent coding genesz
The top 5 enriched Gene Ontology analysis of the ceRNA network
| GO ID | Category | GO term | Target genes | Fold Enrichment | P Value |
|---|---|---|---|---|---|
| GO:0060267 | Biological process | Positive regulation of respiratory burst | INSR;IGHA2 | 43.56349 | 0.00160 |
| GO:0003208 | Biological process | Cardiac ventricle morphogenesis | HEY2;HIF1A | 32.66865 | 0.00255 |
| GO:1903599 | Biological process | Positive regulation of mitophagy | HIF1A | 25.93386 | 0.04539 |
| GO:0097084 | Biological process | Vascular smooth muscle cell development | HEY2 | 25.93386 | 0.04539 |
| GO:0051000 | Biological process | Positive regulation of nitric-oxide synthase activity | DHFR;HIF1A | 25.93386 | 0.04539 |
| GO:0097025 | Cellular component | MPP7-DLG1-LIN7 complex | DLG1 | 25.99559 | 0.04525 |
| GO:0061700 | Cellular component | GATOR2 complex | WDR59 | 25.99559 | 0.04525 |
| GO:0000176 | Cellular component | Nuclear exosome (RNase complex) | EXOSC3;EXOSC2 | 20.13561 | 0.00577 |
| GO:0000178 | Cellular component | Exosome (RNase complex) | EXOSC3;EXOSC2 | 18.69629 | 0.00656 |
| GO:0032982 | Cellular component | Myosin filament | MYOM2;MYH6 | 16.35741 | 0.00828 |
| GO:0019887 | Molecular function | Protein kinase regulator activity | CSNK2B;CDK5RAP1 | 32.84127 | 0.00252 |
| GO:0031404 | Molecular function | Chloride ion binding | ACE | 26.07087 | 0.04515 |
| GO:0008483 | Molecular function | Transaminase activity | AMT | 26.07087 | 0.04515 |
| GO:0034711 | Molecular function | Inhibin binding | IGSF1 | 26.07087 | 0.04515 |
| GO:0031434 | Molecular function | Mitogen-activated protein kinase kinase binding | ACE;DLG1 | 17.50794 | 0.00736 |
The top 5 enriched pathways analysis of the ceRNA network
| KEGG ID | KEGG term | Target genes | Fold Enrichment | |
|---|---|---|---|---|
| path:hsa00030 | Pentose phosphate pathway | RPEL1;RPE;PGD;PRPS2 | 17.6731 | 0.00014 |
| path:hsa00040 | Pentose and glucuronate interconversions | RPEL1;RPE;SORD | 10.4727 | 0.00398 |
| path:hsa00630 | Glyoxylate and dicarboxylate metabolism | AMT;HYI | 8.8265 | 0.02526 |
| path:hsa00051 | Fructose and mannose metabolism | SORD;PMM2 | 7.7188 | 0.03189 |
| path:hsa04630 | JAK-STAT signaling pathway | IL13RA1;LEPR;IFNE;IFNAR1 | 3.2251 | 0.04288 |